tm
Seeing Is Believing
tm
Seeing Is Believing
CVKD is currently covered by 1 analysts with an average price target of $27.81. This is a potential upside of $14.11 (102.99%) from yesterday's end of day stock price of $13.7.
Cadrenal Therapeutics, Common Stock's activity chart (see below) currently has 0 price targets and 2 ratings on display. The stock rating distribution of CVKD is 100% BUY.
Highest price target for CVKD is $32, Lowest price target is $32, average price target is $32.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 11-Nov-2024. First documented stock forecast 06-Jun-2024.
Currently out of the existing stock ratings of CVKD, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$32
$18.14 (130.88%)
7 months 5 days ago
(11-Nov-2024)
0/1 (0%)
$14.11 (78.87%)
What is CVKD (Cadrenal Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on CVKD (Cadrenal Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on CVKD (Cadrenal Therapeutics, Common Stock)?
Which analyst is the currently most bullish on CVKD (Cadrenal Therapeutics, Common Stock)?
